Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

featured

Published in Oncology and

Expert Opinion / Interview · June 10, 2020

ASCO: Early Data on the Gut Microbiome and Outcomes in RCC

Interview by: Sumanta Kumar Pal MD
Interview with: Nazli Dizman MD

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Additional Info

Disclosures

Disclosure statements are available on the authors' profiles:

Nazli Dizman MD

Sumanta Pal MD

featured

Association of Prostate-Specific Antigen Screening With 15-Year Prostate Cancer Mortality

JAMA · April 25, 2024
featured

Tissue-Specific Thresholds of Mutation Burden Associated With Anti–PD-1/Anti–PD-L1 Therapy Benefit and Prognosis in Microsatellite-Stable Cancers

Nat Cancer · April 24, 2024

updated
featured

Early Incorporation of Palliative Care in Patients With Advanced NSCLC

Oncologist · April 24, 2024
story of the week

Remission Induction vs Immediate Allogeneic HSCT for Relapsed or Poorly Responsive AML

Lancet Haematol · April 24, 2024
story of the week

Alectinib for Resected ALK-Positive NSCLC

N. Engl. J. Med · April 23, 2024
featured

Afamitresgene Autoleucel for Advanced Synovial Sarcoma and Myxoid Round Cell Liposarcoma

Lancet · April 18, 2024
featured

First-Line Sintilimab With Pegaspargase, Gemcitabine, and Oxaliplatin for Advanced Extranodal Natural Killer/T-Cell Lymphoma

Lancet Haematol · April 17, 2024
featured

Pembrolizumab Plus Concurrent Chemoradiotherapy for Locally Advanced HNSCC

Lancet Oncol · April 17, 2024
featured

Preoperative Durvalumab or Durvalumab Plus Tremelimumab for Resectable HNSCC

Clin. Cancer Res · April 16, 2024

updated
story of the week

Pembrolizumab With Chemoradiotherapy Followed by Pembrolizumab for Newly Diagnosed, High-Risk, Locally Advanced Cervical Cancer

Lancet · April 16, 2024

updated
story of the week

Association Between Chronic Stress and Metastasis in Patients With Cancer

Cancer Cell · April 16, 2024

Renal Cell Carcinoma

ASCO: Early Data on the Gut Microbiome and Outcomes in RCC

Additional Info

Further Reading

Association of Prostate-Specific Antigen Screening With 15-Year Prostate Cancer Mortality

Tissue-Specific Thresholds of Mutation Burden Associated With Anti–PD-1/Anti–PD-L1 Therapy Benefit and Prognosis in Microsatellite-Stable Cancers

Early Incorporation of Palliative Care in Patients With Advanced NSCLC

Remission Induction vs Immediate Allogeneic HSCT for Relapsed or Poorly Responsive AML

Alectinib for Resected ALK-Positive NSCLC

Afamitresgene Autoleucel for Advanced Synovial Sarcoma and Myxoid Round Cell Liposarcoma

First-Line Sintilimab With Pegaspargase, Gemcitabine, and Oxaliplatin for Advanced Extranodal Natural Killer/T-Cell Lymphoma

Pembrolizumab Plus Concurrent Chemoradiotherapy for Locally Advanced HNSCC

Preoperative Durvalumab or Durvalumab Plus Tremelimumab for Resectable HNSCC

Pembrolizumab With Chemoradiotherapy Followed by Pembrolizumab for Newly Diagnosed, High-Risk, Locally Advanced Cervical Cancer

Association Between Chronic Stress and Metastasis in Patients With Cancer

Related Videos